Current Clinical Trials

SCHWAB FAMILY CANCER CENTER CLINICAL TRIALS OPEN FOR ENROLLMENT 
                                                   (as of June 20, 2016)

HEMATOLOGY STUDIES

•  PCYC-1134M-Pharmacyclics informCLL™: A Disease Registry for Patients with Chronic  
   Lymphocytic Leukemia

https://clinicaltrials.gov/ct2/show/NCT02582879?term=informCLL&rank=1

•  Celgene Connect MDS/AML-The Myelodysplastic Syndromes (MDS) and Acute Myeloid 
   Leukemia (AML) Disease Registry

https://clinicaltrials.gov/ct2/show/NCT01688011?term=Connect+MDS%2FAML&rank=1


BREAST CANCER

•  ALLIANCE A011106- ALTernate approaches for clinical stage II or III Estrogen Receptor
   positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women:
   A Phase III Study

https://clinicaltrials.gov/ct2/show/NCT01953588?term=A011106&rank=1

•  ECOG E2112- A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in
   Men and Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer

https://clinicaltrials.gov/ct2/show/NCT02115282?term=E2112&rank=1
 
•  Agendia FLEX: MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

https://www.clinicaltrials.gov/ct2/show/NCT03053193?term=agendia+flex+mammaprint+registry&rank=1


COLON CANCER

•  SWOG S0820 PACES Study- A Double Blind Placebo-Controlled Trial of Eflornithine and
   Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal
   Cancers in Patients with Stage 0-III Colon or Rectal Cancer, Phase III – Preventing 
   Adenomas of the Colon with Eflornithine and Sulindac (PACES)

https://clinicaltrials.gov/ct2/show/NCT01349881?term=SWOG+S0820&rank=1


LUNG CANCER

•  SWOG S1400- LUNG MAP STUDY- Phase II/III Biomarker-Driven Master Protocol for
   Previously Treated Squamous Cell Lung Cancer (Lung-Map)

https://clinicaltrials.gov/ct2/show/NCT02154490?term=SWOG+S1400&rank=1

•  ALLIANCE A151216 ALCHEMIST STUDY- Adjuvant Lung Cancer Enrichment Marker
   Identification and Sequencing Trial (ALCHEMIST) 

https://clinicaltrials.gov/ct2/show/NCT02194738?term=ALLIANCE+A151216+ALCHEMIST+STUDY&rank=1


OTHER SOLID TUMOR STUDIES

•  ECOG-ACRIN EAY131- MATCH Study- Molecular Analysis for Therapy Choice (MATCH)

https://clinicaltrials.gov/ct2/show/NCT02465060?term=ECOG-ACRIN+EAY131&rank=1